S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PFE Pfizer Inc

25.9403

0.3203 (1.25%)

Pre Market

Last Updated: 22:17:35

Delayed by 15 minutes

Pfizer pulls anti-smoking drug citing potential cancer-causing agent

To read the full story on Seeking Alpha, click here.

Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Pfizer Charts.

Pfizer (NYSE:PFE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Pfizer Charts.

Pfizer Inc News

Pfizer Reports First-Quarter 2024 Results
Wednesday 1 May 2024 (2 hours ago) • Business Wire

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
Tuesday 30 April 2024 (2 days ago) • Business Wire

Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
Monday 29 April 2024 (2 days ago) • Business Wire

Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News
Friday 26 April 2024 (5 days ago) • IH Market News

U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Friday 26 April 2024 (5 days ago) • Business Wire

Pfizer Declares Second-Quarter 2024 Dividend
Thursday 25 April 2024 (7 days ago) • Business Wire

Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News
Wednesday 24 April 2024 (1 week ago) • IH Market News

European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Monday 22 April 2024 (1 week ago) • Business Wire

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Friday 12 April 2024 (3 weeks ago) • Business Wire

Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News
Wednesday 10 April 2024 (3 weeks ago) • IH Market News

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Tuesday 9 April 2024 (3 weeks ago) • Business Wire

ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
Tuesday 9 April 2024 (3 weeks ago) • PR Newswire (US)

More Pfizer Inc News Articles

AUD vs US Dollar

Invesco QQQ Trust Series 1

Commonwealth Bank Of Aus...

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions